The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation
Open accessAbstract
Among the various immunological and non-immunological tumor-promoting activities of myeloid-derived suppressor cells (MDSCs), their immunosuppressive capacity remains a key hallmark. Effort in the past decade has provided us with a clearer view of the suppressive nature of MDSCs. More suppressive pathways have been identified, and their recognized targets have been expanded from T cells and natural killer (NK) cells to other immune cells. These novel mechanisms and targets afford MDSCs versatility in suppressing both innate and adaptive immunity. On the other hand, a better understanding of the regulation of their development and function has been unveiled. This intricate regulatory network, consisting of tumor cells, stromal cells, soluble mediators, and hostile physical conditions, reveals bi-directional crosstalk between MDSCs and the tumor microenvironment. In this article, we will review available information on how MDSCs exert their immunosuppressive function and how they are regulated in the tumor milieu. As MDSCs are a well-established obstacle to anti-tumor immunity, new insights in the potential synergistic combination of MDSC-targeted therapy and immunotherapy will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–227 of 227
Veirman, K. D., Beule, N. D., Maes, K., Menu, E., Bruyne, E. D., Raeve, H. D., Fostier, K., Moreaux, J., Kassambara, A., Hose, D., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0192 · Cited by 58
Ren, J. P., Zhao, J., Dai, J., Griffin, J. W. D., Wang, L., Wu, X. Y., Morrison, Z. D., Li, G. Y., Gazzar, M. E., Ning, S., et al. (2016) · Immunology · doi:10.1111/imm.12616 · Cited by 55
Nam, S., Kang, K., Seon, J., Kim, J. W., Lee, H. G., Kim, Y., Yang, Y. D., Lee, M.-S., & Lim, J. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0215-068rr · Cited by 55
Self-citationHammami, A., Abidin, B. M., Charpentier, T., Fabié, A., Duguay, A.-P., Heinonen, K. M., & Stäger, S. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006616 · Cited by 55
Lowe, D. B., Bose, A., Taylor, J. L., Tawbi, H. A.-H., Lin, Y., Kirkwood, J. M., & Storkus, W. J. (2014) · OncoImmunology · doi:10.4161/onci.27589 · Cited by 54
Sato, Y., Shimizu, K., Shinga, J., Hidaka, M., Kawano, F., Kakimi, K., Yamasaki, S., Asakura, M., & Fujii, S. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.995541 · Cited by 51
Generation and functional characterization of MDSC-like cells
Heine, A., Held, S. A. E., Schulte-Schrepping, J., Wolff, J. F. A., Klee, K., Ulas, T., Schmacke, N. A., Daecke, S. N., Riethausen, K., Schultze, J. L., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1295203 · Cited by 51
Green, K. A., Wang, L., Noelle, R. J., & Green, W. R. (2015) · Journal of Virology · doi:10.1128/jvi.00888-15 · Cited by 46
Myeloid-derived suppressor cells promote B-cell production of IgA in a TNFR2-dependent manner
Xu, X., Meng, Q., Erben, U., Wang, P., Glauben, R., Kühl, A. A., Wu, H., Ma, C. W., Hu, M., Wang, Y., et al. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.103 · Cited by 45
Nguyen-Pham, T.-N., Jung, S., Vo, M.-C., Thanh-Tran, H.-T., Lee, Y.-K., Lee, H., Choi, N.-R., Hoang, M.-D., Kim, H., & Lee, J. (2015) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000097 · Cited by 44
Zhang, H., Li, Z., Wang, L., Tian, G., Tian, J., Yang, Z., Cao, G., Zhou, H. Y., Zhao, L., Wu, Z., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00129 · Cited by 42
Wang, S.-H., Lu, Q., Guo, Y., Song, Y., Liu, P., & Wang, Y. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.08.019 · Cited by 41
Zhang, Z., Yi, N., Zhang, T., Zhang, L., Wu, X., Liu, M., Fu, Y., He, S., Jiang, Y., Ding, H., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001471 · Cited by 39
Rastad, J. L., & Green, W. R. (2016) · Virology · doi:10.1016/j.virol.2016.08.031 · Cited by 38
Shime, H., Kojima, A., Maruyama, A., Saito, Y., Oshiumi, H., Matsumoto, M., & Seya, T. (2013) · Journal of Innate Immunity · doi:10.1159/000355126 · Cited by 37
A Myeloid Cell Population Induced by Freund Adjuvant Suppresses T-cell−mediated Antitumor Immunity
Wang, Z., Jiang, J., Li, Z., Zhang, J., Wang, H., & Qin, Z. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181bed2ba · Cited by 37
Baker, G. J., Chockley, P. J., Zamler, D. B., Castro, M. G., & Lowenstein, P. R. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1163461 · Cited by 36
Passive Transfer of Tumour‐Derived MDSC s Inhibits Asthma‐Related Airway Inflammation
Song, C., Yuan, Y., Wang, X., Li, D., Zhang, G. ‐., Huang, B., & Feng, Z. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12140 · Cited by 34
Li, C., Liu, T., Bazhin, A. V., & Yang, Y. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25726 · Cited by 29
Self-citationFuse, H., Tomihara, K., Heshiki, W., Yamazaki, M., Takei, R., Tachinami, H., Furukawa, K.-I., Sakurai, K., Rouwan, M., & Noguchi, M. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.05.012 · Cited by 27
Tähtinen, S., Blattner, C., Vähä-Koskela, M. J. V., Saha, D., Siurala, M., Parviainen, S., Utikal, J. S., Kanerva, A., Umansky, V., & Hemminki, A. (2016) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000144 · Cited by 27
Drabczyk-Pluta, M., Werner, T., Hoffmann, D. E., Leng, Q., Chen, L., Dittmer, U., & Zelinskyy, G. (2017) · Retrovirology · doi:10.1186/s12977-017-0364-3 · Cited by 25
Lin, Y., Wang, B., Wei, S., Tan, Y., Feng, J., Xu, L., Wang, L., Han, B., Zhang, M., Yu, J., et al. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.11.005 · Cited by 25
Spallanzani, R. G., Dalotto‐Moreno, T., Iraolagoitia, X. L. R., Ziblat, A., Domaica, C. I., Avila, D. E., Rossi, L. E., Fuertes, M. B., Battistone, M. A., Rabinovich, G. A., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1483-x · Cited by 22
Koike, Y., Kanai∥, T., Saeki, K., Nakamura, Y., Nakano, M., Mikami, Y., Yamagishi, Y., Nakamoto, N., Ebinuma, H., & Hibi∥, T. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.08.008 · Cited by 20
Müller‐Leisse, J., Brueggemann, S., Bouzani, M., Schmitt, A., Einsele, H., & Loeffler, J. (2015) · Medical Mycology · doi:10.1093/mmy/myv030 · Cited by 18
Li, Q., Liu, Y., Wang, S., Gong, W., Jia, X., Liu, L., Feng, Y., Ding, J.-J., Xu, Y., Fu, Y., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13124 · Cited by 12
Cited by
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
Maalej, K. M., Merhi, M., Inchakalody, V. P., Mestiri, S., Alam, M., Maccalli, C., Cherif, H., Uddin, S., Steinhoff, M., Marincola, F. M., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01723-z · Cited by 618
T cell receptor (TCR) signaling in health and disease
Shah, K., Al-Haidari, A., Sun, J., & Kazi, J. U. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00823-w · Cited by 604
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 460
Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition
Taki, M., Abiko, K., Ukita, M., Murakami, R., Yamanoi, K., Yamaguchi, K., Hamanishi, J., Baba, T., Matsumura, N., & Mandai, M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4459 · Cited by 351
Metadata
- Authors
- Yang, Y., Li, C., Liu, T., Dai, X., & Bazhin, A. V.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-07-22
- Volume
- 11
- Pages
- 1371-1371
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3033841996
- Cited by
- 291
- References
- 227
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.